Life Sciences

Gilholm Harrison attorneys have extensive experience in all aspects of securing patent protection in the Life Sciences - biotechnology, pharmaceuticals, diagnostics, organic and inorganic chemistry. We advise Universities, spin out companies and large and small pharmaceutical companies with respect to patentability, freedom to operate, opposition/revocation and supplementary protection certificates.

We work closely with clients to identify patent filing strategies which support both licensing and the development of patent portfolios in order to enable companies to secure a competitive position in businesses that depend on strong and enforceable intellectual property.

We have particular experience in cancer therapy and diagnostics, cardiovascular therapy, stem cells, especially embryonic stem cells, immunology, natural products, transgenic plants, tissue engineering, protein pharmaceuticals, fusion proteins and organic chemistry.

If you have a patent matter that you would like to discuss, please contact either Dr Michelle O'Neill or Dr Rob Docherty.

We also provide advice with respect to licensing and the negotiation of favourable terms when dealing with the biotechnology or pharmaceutical industry. If you would like to discuss any matters relating to licensing or negotiating a business deal, please contact our licensing executive, Dr Deborah Carter.